GlassScriptPhysician profile
Firas Bukai
NPI 1841338415
$3,509.19
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.08 · 2020: $542 · 2021: $626 · 2022: $1,345 · 2023: $963.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675 · Education: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.00 |
| Education | $287.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $2,834.65 | 2020-2023 | |
| Planmeca USA, INC. | $229.98 | 2020 | |
| Align Technology, INC. | $200.58 | 2020-2022 | |
| Patterson Companies, INC. | $149.50 | 2020 | |
| Straumann USA LLC | $50.00 | 2020 | |
| Philips North America LLC | $29.48 | 2019-2021 | |
| Nobel Biocare USA | $15.00 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Firas Bukai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.